From St Luke's-Roosevelt Hospital, University Hospital of Columbia University College of Physicians and Surgeons, Division of Breast Surgery, Department of Surgery, New York, NY.
This article was corrected | View correction
A 53-year-old woman of male genotype sought care at the emergency department with complaints of right breast swelling, erythema, mastodynia, and bilateral palpable breast nodules. The patient had undergone male-to-female sex change surgery more than a decade previously and developed female-looking breasts by using hormonal therapy but was dissatisfied with the results. She had had liquid silicone of unknown purity and manufacturer injected directly into both breasts illicitly 2 months before seeking care.
The patient's vital signs were stable, and she was initially afebrile. Physical examination revealed a markedly enlarged, tender, and indurated right breast. Bilaterally there were firm, mobile palpable breast nodules with no axillary adenopathy. She had been treated by her internist as an outpatient with multiple courses of oral antibiotics with no improvement. Computed tomography of the chest had been performed 1 week earlier, and a representative image is shown in Figure 1.
A.Inflammatory carcinoma B.Cystosarcoma phyllodes tumor C.Silicone mastitis with abscess D.Extensive fat necrosis
Corresponding author: Gladys L. Giron, MD, St Luke's-Roosevelt Hospital Center, Division of Breast Surgery, 425 W 59th St, Suite 7A, New York, NY 10019 (e-mail: firstname.lastname@example.org).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature
Users' Guides to the Medical Literature
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.